These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2764989)

  • 1. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
    Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T
    Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin K-reversible hypoprothrombinemia in rats: comparison of hypoprothrombinemic changes in various strains of rats caused by vitamin K deficiency and antibiotic treatment.
    Matsuura M; Satoh S; Kobayashi F; Uchida K; Matsubara T
    J Toxicol Sci; 1989 Aug; 14(3):165-80. PubMed ID: 2810399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin K reversible hypoprothrombinemia in rats. II. Efficacy of vitamin K on latamoxef-induced coagulopathy in rats.
    Matsuura M; Satoh S; Kobayashi F; Matsubara T; Uchida K
    Jpn J Pharmacol; 1988 Aug; 47(4):357-65. PubMed ID: 3184567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin K-reversible hypoprothrombinemia in rats. I. Sex differences in the development of hypoprothrombinemia and the effects of beta-lactam antibiotics.
    Matsuura M; Satoh S; Takano K; Harauchi T; Yoshizaki T; Kobayashi F; Matsubara T; Uchida K
    Jpn J Pharmacol; 1988 Mar; 46(3):303-10. PubMed ID: 3379837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of beta-lactam antibiotics and heterocyclic thiol compounds on vitamin K-dependent carboxylation activity and blood coagulation factors in vitamin K-deficient rats.
    Oka T; Touchi A; Harauchi T; Takano K; Yoshizaki T; Matsubara T
    Biochem Pharmacol; 1988 May; 37(10):2091-5. PubMed ID: 3377812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA; Suttie JW
    Thromb Res; 1986 Oct; 44(2):147-53. PubMed ID: 3787564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro effect of beta-lactam antibiotics and N-methyltetrazolethiol on microsomal vitamin K epoxide reductase in rats.
    Kawamoto K; Touchi A; Sugeno K; Matsubara T
    Jpn J Pharmacol; 1988 Jun; 47(2):169-78. PubMed ID: 3199593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on oxacephem antibiotics: comparison of the effects of 1-oxa and 1-thia cephalosporins on blood coagulation activities and vitamin K metabolism in rats.
    Uchida K; Matsubara T; Hirauchi K
    Jpn J Pharmacol; 1989 Jul; 50(3):283-8. PubMed ID: 2761130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of warfarin resistance and liver microsomal vitamin K epoxide reductase activity in rats.
    MacNicoll AD
    Biochim Biophys Acta; 1985 May; 840(1):13-20. PubMed ID: 3995080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH; Baars LG
    Biochem Pharmacol; 1989 Apr; 38(7):1115-20. PubMed ID: 2706010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats.
    Yamanaka Y; Yamano M; Yasunaga K; Shike T; Uchida K
    Thromb Res; 1990 Jan; 57(2):205-14. PubMed ID: 2315885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulopoietin activity in rat plasma: influence of degree of hypoprothrombinemia and reproducibility of the response.
    Shah DV; Suttie JW
    Thromb Res; 1985 Jul; 39(1):43-7. PubMed ID: 4035649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ; Principe LM; Walsh WA; Friedman PA
    Biochemistry; 1983 Nov; 22(24):5655-60. PubMed ID: 6652076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1.
    Wallin R; Patrick SD; Martin LF
    Int J Biochem; 1987; 19(11):1063-8. PubMed ID: 3428478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target-based warfarin pharmacokinetics in the rat: the link with the anticoagulant effect.
    Thijssen HH; Janssen YP
    J Pharmacol Exp Ther; 1994 Aug; 270(2):554-8. PubMed ID: 8071848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH; Janssen YP; Vervoort LT
    Biochem J; 1994 Jan; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM; Cai D; Wallin R
    Biochem Pharmacol; 1998 Jan; 55(2):169-75. PubMed ID: 9448739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC; Suttie JW
    Arch Biochem Biophys; 1984 Nov; 234(2):405-12. PubMed ID: 6497379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.